George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.50
Bid: 372.50
Ask: 374.00
Change: 8.50 (2.33%)
Spread: 1.50 (0.403%)
Open: 368.50
High: 374.50
Low: 365.00
Prev. Close: 365.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NGCD NOTIFICATION

5 Sep 2018 07:00

RNS Number : 7740Z
Chemring Group PLC
05 September 2018
 

FOR IMMEDIATE RELEASE 5 SEPTEMBER 2018

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

NGCD NOTIFICATION

 

Chemring is pleased to announce that its US based subsidiary, Chemring Sensors and Electronic Systems (CSES), has been notified that it has been down selected as one of the suppliers on the first stream of the Next Generation Chemical Detector (NGCD1). NGCD1, now known as the Aerosol & Vapour Chemical Agent Detector (AVCAD), is the long-term Program of Record for the US Department of Defense to detect traditional and advanced threat vapours, and liquid and solid aerosols.

 

The resultant contract award, which is expected to be received in the coming months, is expected to take the form of an indefinite delivery, indefinite quantity (IDIQ) contract and will be for the Engineering and Manufacturing Development of the program, together with options for varying quantities of hardware under Low Rate Initial Production and Full Rate Production phases of the program.

 

Michael Ord, Group Chief Executive of Chemring, commented:

 

"As the largest stream under the NGCD Program of Record, the AVCAD award decision is a significant development for Chemring and is the culmination of a number of years of research and development activity. We are delighted to have been chosen on this long-term program."

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY18 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTFZLLBVKFZBBZ
Date   Source Headline
16th Dec 20197:00 amRNSResults for the year ended 31 October 2019
11th Dec 201910:20 amRNSHolding(s) in Company
2nd Dec 201912:13 pmRNSTotal Voting Rights
26th Nov 20191:23 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSDisposal of Chemring Ordnance
6th Nov 20192:34 pmRNSHolding(s) in Company
1st Nov 201910:57 amRNSTotal Voting Rights
1st Nov 20197:00 amRNSContract award and year-end update
14th Oct 20194:32 pmRNSDirector/PDMR Shareholding
1st Oct 201912:09 pmRNSTotal Voting Rights
13th Sep 201912:55 pmRNSHolding(s) in Company
13th Sep 201912:52 pmRNSHolding(s) in Company
12th Sep 20192:29 pmRNSHolding(s) in Company
11th Sep 20197:00 amRNSContract Awards
11th Sep 20197:00 amRNSTrading Update
4th Sep 20192:41 pmRNSHolding(s) in Company
2nd Sep 201912:29 pmRNSTotal Voting Rights
1st Aug 201911:04 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSDirectorate Change
4th Jul 20194:22 pmRNSHolding(s) in Company
1st Jul 201910:31 amRNSTotal Voting Rights
24th Jun 201910:09 amRNSBlock listing Update
24th Jun 20199:52 amRNSBlock listing Interim Review
24th Jun 20197:00 amRNSDisposal of Chemring Defence
5th Jun 20197:00 amRNSInterim results
3rd Jun 20199:52 amRNSTotal Voting Rights
10th May 20197:00 amRNSPost Close Statement and Contract Win
1st May 201910:07 amRNSTotal Voting Rights
10th Apr 20192:12 pmRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSDisposal of Chemring Military Products, Inc.
2nd Apr 20195:44 pmRNSHolding(s) in Company
2nd Apr 201910:39 amRNSDirector/PDMR Shareholding
1st Apr 201910:29 amRNSTotal Voting Rights
25th Mar 20195:09 pmRNSDoc re. Ordinary & Special Resolutions
25th Mar 20193:40 pmRNSHolding(s) in Company
25th Mar 20193:36 pmRNSHolding(s) in Company
25th Mar 20198:51 amRNSDirector/PDMR Shareholding
25th Mar 20198:47 amRNSDirector/PDMR Shareholding
25th Mar 20198:47 amRNSDirector/PDMR Shareholding
21st Mar 20192:43 pmRNSResult of AGM
21st Mar 20197:00 amRNSAGM Trading Update
20th Mar 20194:03 pmRNSHolding(s) in Company
19th Mar 20197:11 amRNSDirector Declaration
1st Mar 201911:40 amRNSTotal Voting Rights
21st Feb 201910:27 amRNSDirector/PDMR Shareholding
20th Feb 20191:30 pmRNSNotice of Annual General Meeting
1st Feb 20191:55 pmRNSTotal Voting Rights
18th Jan 201910:17 amRNSDirector/PDMR Shareholding
17th Jan 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 OCTOBER 2018
7th Jan 20198:51 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.